Sientra (SIEN) Reports Q2 Loss of $1.07/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Sientra® Reports Second Quarter 2017 Financial Results
August 9, 2017 4:01 PM EDTRemains on Track for FDA PMA Supplement Approval by End of 2017
Completed Acquisition of Miramar Labs, Inc. and Secured $50 Million Credit Facility
Reached Definitive Settlement with Brazilian Breast Implant Contract Manufacturer
Appoints Keith J. Sullivan to Board of Directors
SANTA BARBARA, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (Sientra or the Company), a medical aesthetics company, today announced its financial results for the second quarter ended June 30, 2017.
Jeffrey M. Nugent,... More
